Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-3_12-cv-05924/USCOURTS-cand-3_12-cv-05924-0/pdf.json

Nature of Suit Code: 365
Nature of Suit: Personal Injury - Product Liability
Cause of Action: 28:1441 Petition for Removal- Product Liability

---

LA/2157793v1 -1- 3:12-cv-05924 JSW 

Stipulation To Stay Motion For Judgment On The Pleadings Pending Outcome Of Motion To Remand; 

[proposed] Order

 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28

SEDGWICK LLP 

Karen Woodward (State Bar No. 205543) 

Christopher P. Norton (State Bar No. 234621) 

801 S. Figueroa Street, 19th Floor 

Los Angeles, California 90017-5556 

karen.woodward@sedgwicklaw.com 

christopher.norton@sedgwicklaw.com 

Telephone: (213) 426-6900 

Facsimile: (213) 426-6921 

Attorneys for Defendant 

XANODYNE PHARMACEUTICALS, INC. 

UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF CALIFORNIA 

MARY KEENE, et al., 

Plaintiffs, 

v. 

MCKESSON CORPORATION, et al., 

 Defendants. 

CASE NO. 3:12-cv-05924 JSW

Assigned to the Hon. Jeffrey S. White 

STIPULATION TO STAY MOTION FOR 

JUDGMENT ON THE PLEADINGS 

PENDING OUTCOME OF MOTION TO 

REMAND; [PROPOSED] ORDER 

TO ALL PARTIES AND THEIR ATTORNEYS OF RECORD: 

Defendant Xanodyne Pharmaceuticals, Inc. (“Xanodyne”) and plaintiffs hereby agree and 

stipulate to STAY Xanodyne’s Motion for Partial Judgment on the Pleadings as follows: 

Plaintiffs’ action was removed by Defendants Teva Pharmaceuticals, Inc. to the United 

States District Court for the Northern District of California on November 20, 2012. 

On December 17, 2012, Xanodyne filed a Motion for Judgment on the Pleadings based 

on lack of personal jurisdiction. Plaintiffs’ opposition to that motion was due December 31, 

2012. The hearing on that motion is set for March 8, 2013. 

Plaintiffs will file a Motion to Remand on or before January 3, 2013. 

In order to promote the efficiency for the Court and the parties, Xanodyne and plaintiffs 

have agreed to stay Xanodyne’s Motion for Judgment on the Pleadings pending the outcome of 

Case 3:12-cv-05924-JST Document 28 Filed 01/04/13 Page 1 of 2 Case3:12-cv-05924-JSW Document25 Filed01/02/13 Page1 of 4
LA/2157793v1 -2- 3:12-cv-05924 JSW 

Stipulation To Stay Motion For Judgment On The Pleadings Pending Outcome Of Motion To Remand; 

[proposed] Order

 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28

the Motion to Remand. 

ON THESE BASES, plaintiffs and Xanodyne agree that: 

Xanodyne’s Motion for Judgment on the Pleadings is stayed pending the outcome of the 

Motion to Remand; 

IT IS SO STIPULATED. 

DATED: January 2, 2013 SEDGWICK LLP 

By: /s/ Christopher P. Norton 

 KAREN WOODWARD 

CHRISTOPHER P. NORTON 

Attorneys for Defendant 

Xanodyne Pharmaceuticals, Inc. 

DATED: January 2, 2013 SALKOW LAW, APC 

By: /s/ Richard Salkow 

 RICHARD SALKOW 

 Attorneys for Plaintiffs 

PURSUANT TO STIPULATION, 

IT IS SO ORDERED. 

This _______ day of ______________, 2013. 

 

 ______________________________ 

 The Honorable Jeffrey S. White 

 United States District Judge 

Case3:12-cv-05924-JSW Document25 Filed01/02/13 Page2 of 4

The Court deems Xanodyne's motion for judgment on the pleadings as withdrawn. If the Court 

denies Plaintiffs' motion to remand, Xanodyne may re-file its motion. 4th January 

Case 3:12-cv-05924-JST Document 28 Filed 01/04/13 Page 2 of 2